The intraday gains of innovative drugs and CRO concepts expanded. Nanmo Biotech rose 20 cm, and nearshore protein and pepsis rose more than 10%, both of which reached record highs. Previously, Cansino, Tenomebo, Kangchen Pharmaceutical, and Osecon had higher gains.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.